Even though OCT4 expression was not significantly correlated with any clinicopathologic parameter and showed no impact on patient survival in our cohort of sarcoma patients, we cannot discard that the analysis of larger series of patients could unravel a clinically relevant role for OCT4 in specific sarcoma subtypes. Here, POU5F1 is linked to sarcoma.